Gaithersburg-based biotech firm MedImmune and the University of Maryland, Baltimore (UMB), have embarked on a five-year, $6 million partnership to push bioscience research in Maryland.
According to a press release:
MedImmune and UMB will both contribute funding and scientists to work on joint research projects, and will provide opportunities for scientific exchange and educational training between MedImmune and UMB scientists, students, and post docs.
MedImmune is contributing $5 million to the fund, with the remaining $1 million coming from UMB.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
The person charged in the UnitedHealthcare CEO shooting had a ton of tech connections
From rejection to innovation: How I built a tool to beat AI hiring algorithms at their own game
Where are the country’s most vibrant tech and startup communities?
